cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.8319971
title: Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma

description: <b>Background:</b> Neoadjuvant therapy is a strategy for resectable and borderline resectable pancreatic cancer, but a consensus approach regarding optimal management is undetermined. Neoadjuvant options include chemotherapy with/without radiotherapy. Stereotactic body radiation therapy (SBRT) is a novel radiation technique that may provide benefit over conventionally fractionated radiation therapy (CFRT) in the neoadjuvant setting. The purpose of the present study is to determine neoadjuvant treatment with SBRT to other neoadjuvant treatment options for patients with resectable pancreatic cancer. <b>Material and methods:</b> The National Cancer Database was queried (2004–2015) for patients with nonmetastatic pancreatic adenocarcinoma receiving neoadjuvant therapy followed by pancreatectomy. Patients were categorized based on the type of neoadjuvant treatment administered. Statistics included temporal trend assessment by annual percent change (APC), predictors for SBRT by multivariable logistic regression, Kaplan–Meier overall survival (OS) analysis without and with propensity matching, and Cox proportional hazards modeling for univariable OS analysis. <b>Results:</b> Of 5828 patients, 332 (5.7%), 3234 (55.5%) and 2262 (38.8%) received neoadjuvant chemo-SBRT, chemotherapy, and chemo-CFRT, respectively. SBRT utilization increased from 0% in 2004 to 9.5% in 2015, with a greater APC after 2010 (<i>p</i> &lt; .001). SBRT was more likely to be utilized in patients with T3–4 and node-positive disease (<i>p</i> &lt; .05 for all). The chemo-SBRT cohort was associated with a higher OS rate before and after propensity matching (<i>p</i> &lt; .05 for both). The rate of R0 resection was higher in radiotherapy groups than the chemotherapy cohort (<i>p</i> &lt; .001). <b>Conclusions:</b> Utilization of neoadjuvant SBRT for pancreatic cancer is increasing. In the neoadjuvant setting, chemo-SBRT may improve R0 resection and OS over chemotherapy and chemo-CFRT, although confirmatory prospective studies are needed for confirmation.
DOI: 10.6084/m9.figshare.8319971.v1
title: Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma

description: <b>Background:</b> Neoadjuvant therapy is a strategy for resectable and borderline resectable pancreatic cancer, but a consensus approach regarding optimal management is undetermined. Neoadjuvant options include chemotherapy with/without radiotherapy. Stereotactic body radiation therapy (SBRT) is a novel radiation technique that may provide benefit over conventionally fractionated radiation therapy (CFRT) in the neoadjuvant setting. The purpose of the present study is to determine neoadjuvant treatment with SBRT to other neoadjuvant treatment options for patients with resectable pancreatic cancer. <b>Material and methods:</b> The National Cancer Database was queried (2004–2015) for patients with nonmetastatic pancreatic adenocarcinoma receiving neoadjuvant therapy followed by pancreatectomy. Patients were categorized based on the type of neoadjuvant treatment administered. Statistics included temporal trend assessment by annual percent change (APC), predictors for SBRT by multivariable logistic regression, Kaplan–Meier overall survival (OS) analysis without and with propensity matching, and Cox proportional hazards modeling for univariable OS analysis. <b>Results:</b> Of 5828 patients, 332 (5.7%), 3234 (55.5%) and 2262 (38.8%) received neoadjuvant chemo-SBRT, chemotherapy, and chemo-CFRT, respectively. SBRT utilization increased from 0% in 2004 to 9.5% in 2015, with a greater APC after 2010 (<i>p</i> &lt; .001). SBRT was more likely to be utilized in patients with T3–4 and node-positive disease (<i>p</i> &lt; .05 for all). The chemo-SBRT cohort was associated with a higher OS rate before and after propensity matching (<i>p</i> &lt; .05 for both). The rate of R0 resection was higher in radiotherapy groups than the chemotherapy cohort (<i>p</i> &lt; .001). <b>Conclusions:</b> Utilization of neoadjuvant SBRT for pancreatic cancer is increasing. In the neoadjuvant setting, chemo-SBRT may improve R0 resection and OS over chemotherapy and chemo-CFRT, although confirmatory prospective studies are needed for confirmation.
DOI: 10.6084/m9.figshare.8320028
title: tree files of phylogenetic analysis

description: tree files of phylogenetic analysis
DOI: 10.6084/m9.figshare.8320028.v1
title: tree files of phylogenetic analysis

description: tree files of phylogenetic analysis
DOI: 10.6084/m9.figshare.8320031
title: the alignment of phylogenetic analysis

description: the alignment of phylogenetic analysis
DOI: 10.6084/m9.figshare.8320031.v1
title: the alignment of phylogenetic analysis

description: the alignment of phylogenetic analysis
DOI: 10.25829/ja2s47
title: Americas species richness by macrogroup
DOI: 10.6084/m9.figshare.25097297
title: Additional file 1 of A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

description: Additional file 1: Figure S1. The forest plot of consistency test of SAEs. Figure S2. Forest plot of pairwise comparison of the incidence of SAEs.  (PLA: Placebo; NIN:Nintedanib; PIR: Pirfenidone; SIL: Sildenafil; AMB: Ambrisentan; PAM: Pamrevlumab; BOS: Bosentan; MAC: Macitentan; IMA: Imatinib; GLPG:GLPG1690; SIM: Simtuzumab; WAR: Warfarin; PRM: PRM151;NAC:N-acetylcysteine.). Figure S3. SUCRA ranking chart of the incidence of SAEs. Figure S4. The forest plot of consistency test of all-cause mortality. Figure S5. Forest plot of pairwise comparison of all-cause mortality, (PLA: Placebo; NIN: Nintedanib; PIR:Pirfenidone; SIL: Sildenafil; AMB: Ambrisentan; PAM: Pamrevlumab; BOS: Bosentan; MAC:Macitentan; IMA: Imatinib; SIM: Simtuzumab; WAR: Warfarin; NAC:N-acetylcysteine.). Figure S6. SUCRA ranking chart of all-cause mortality. Figure S7. The forest plot of consistency test of FVC (L) absolute change from baseline. Figure S8. Forest plot of pairwise comparison of FVC (L) absolute change from baseline. (PLA: Placebo; NIN: Nintedanib; PAM: Pamrevlumab; BOS: Bosentan; MAC: Macitentan; IMA:Imatinib; GLPG:GLPG1690;WAR:Warfarin; PRM: PRM151;NAC:N-acetylcysteine.). Figure S9. SUCRA ranking chart of FVC (L) absolute change from baseline. Figure S10. The forest plot of consistency test of FVC (% predicted)absolute change from baseline. Figure S11. Forest plot of pairwise comparison of FVC (% predicted) absolute change from baseline. (PLA: Placebo; NIN: Nintedanib; PIR: Pirfenidone; SIL: Sildenafil; AMB: Ambrisentan; PAM: Pamrevlumab; WAR:Warfarin; PRM: PRM151.). Figure S12. SUCRA ranking chart of FVC (% predicted) absolute change from baseline. Figure S13. The forest plot of consistency test of the proportion of patients with decline in FVC≥10% predicted. Figure S14. Forest plot of pairwise comparison of the proportion of patients with decline in FVC≥10% predicted.  (PLA:Placebo; NIN: Nintedanib; PIR: Pirfenidone; AMB: Ambrisentan; PAM: Pamrevlumab; WAR:Warfarin.). Figure S15. SUCRA ranking chart of the proportion of patients with decline in FVC≥10% predicted. Figure S16. The funnel chart of bias generation detected by Begg rank correlation. Figure S17. The funnel chart generated by Egger's test. Figure S18. Influence analysis results of the five main outcomes. Table S1. The search strategy of PubMed. Table S2. Quality evaluation of the 24 included studies. Table S3. Influence analysis results data of the incidence of SAEs. Table S4. Influence analysis results data of all-cause mortality. Table S5. Influence analysis results data of FVC (L) absolute change from baseline. Table S6. Influence analysis results data of FVC (% predicted)absolute change from baseline. Table S7. Influence analysis results data of the proportion of patients with decline in FVC≥10% predicted.
DOI: 10.6084/m9.figshare.25097297.v1
title: Additional file 1 of A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

description: Additional file 1: Figure S1. The forest plot of consistency test of SAEs. Figure S2. Forest plot of pairwise comparison of the incidence of SAEs.  (PLA: Placebo; NIN:Nintedanib; PIR: Pirfenidone; SIL: Sildenafil; AMB: Ambrisentan; PAM: Pamrevlumab; BOS: Bosentan; MAC: Macitentan; IMA: Imatinib; GLPG:GLPG1690; SIM: Simtuzumab; WAR: Warfarin; PRM: PRM151;NAC:N-acetylcysteine.). Figure S3. SUCRA ranking chart of the incidence of SAEs. Figure S4. The forest plot of consistency test of all-cause mortality. Figure S5. Forest plot of pairwise comparison of all-cause mortality, (PLA: Placebo; NIN: Nintedanib; PIR:Pirfenidone; SIL: Sildenafil; AMB: Ambrisentan; PAM: Pamrevlumab; BOS: Bosentan; MAC:Macitentan; IMA: Imatinib; SIM: Simtuzumab; WAR: Warfarin; NAC:N-acetylcysteine.). Figure S6. SUCRA ranking chart of all-cause mortality. Figure S7. The forest plot of consistency test of FVC (L) absolute change from baseline. Figure S8. Forest plot of pairwise comparison of FVC (L) absolute change from baseline. (PLA: Placebo; NIN: Nintedanib; PAM: Pamrevlumab; BOS: Bosentan; MAC: Macitentan; IMA:Imatinib; GLPG:GLPG1690;WAR:Warfarin; PRM: PRM151;NAC:N-acetylcysteine.). Figure S9. SUCRA ranking chart of FVC (L) absolute change from baseline. Figure S10. The forest plot of consistency test of FVC (% predicted)absolute change from baseline. Figure S11. Forest plot of pairwise comparison of FVC (% predicted) absolute change from baseline. (PLA: Placebo; NIN: Nintedanib; PIR: Pirfenidone; SIL: Sildenafil; AMB: Ambrisentan; PAM: Pamrevlumab; WAR:Warfarin; PRM: PRM151.). Figure S12. SUCRA ranking chart of FVC (% predicted) absolute change from baseline. Figure S13. The forest plot of consistency test of the proportion of patients with decline in FVC≥10% predicted. Figure S14. Forest plot of pairwise comparison of the proportion of patients with decline in FVC≥10% predicted.  (PLA:Placebo; NIN: Nintedanib; PIR: Pirfenidone; AMB: Ambrisentan; PAM: Pamrevlumab; WAR:Warfarin.). Figure S15. SUCRA ranking chart of the proportion of patients with decline in FVC≥10% predicted. Figure S16. The funnel chart of bias generation detected by Begg rank correlation. Figure S17. The funnel chart generated by Egger's test. Figure S18. Influence analysis results of the five main outcomes. Table S1. The search strategy of PubMed. Table S2. Quality evaluation of the 24 included studies. Table S3. Influence analysis results data of the incidence of SAEs. Table S4. Influence analysis results data of all-cause mortality. Table S5. Influence analysis results data of FVC (L) absolute change from baseline. Table S6. Influence analysis results data of FVC (% predicted)absolute change from baseline. Table S7. Influence analysis results data of the proportion of patients with decline in FVC≥10% predicted.
DOI: 10.6084/m9.figshare.25303705
title: Don’t Be Do-gooders.csv

description: data of the article Don’t Be Do-gooders
DOI: 10.34740/kaggle/dsv/7722083
title: Pássaros de Antônio Pereira
DOI: 10.6084/m9.figshare.25303705.v1
title: Don’t Be Do-gooders.csv

description: data of the article Don’t Be Do-gooders
DOI: 10.7916/nhej-0s11
title:  Data for: Robust, High-Density Lesion Mapping in the Left Atrium with Near-Infrared Spectroscopy
DOI: 10.15470/dqtuup
title: SIM-Fungal records compiled by Joan Mont?n

description: The dataset contains records compiled by Joan Mont?n since 1996 until present, mainly in Catalonia and Aragon, with remarkably many data from the Pyrenees. Herbarium specimens supporting 1955 records are available (accordingly marked in OtherCatalogNumbers field). Those herbarium numbers which end by a "D" (for istance, 1000D) are deposited in the personal herbarium of Joan Mont?n (digital pictures available), whereas those that lack a "D" in the end (for instance, 487) are deposited in the Herbarium Illerdense (HBIL), located in the Institut d' Estudis Ilerdencs of Lleida (slides available). The dataset comprises records of scarcely recorded species and potentially endangered species in the Iberian Peninsula.
description: Cont? 4951 registres d'observacions i esp?cimens d'herbari recopilats per Joan Mont?n des de 1996 fins al present, principalment a Catalunya i Arag?, i compta amb nombrosos registres del Pirineu. Hi ha esp?cimens d'herbari de 1955 dels registres (refer?ncies al camp OtherCatalogNumbers). Aquells que acaben en D (per exemple, 1000D) es troben dipositats en l'herbari particular de Joan Mont?n, mentre que aquells en qu? nom?s consta un n?mero (per exemple, 487) estan dipositats al Herbarium Illerdense (HBIL), localitzat a l'Institut d' Estudis Ilerdencs de Lleida. El joc de dades cont? registres d'esp?cies poc citades i potencialment amena?ades a la Pen?nsula Ib?rica.
description: Contiene 4951 registros de observaciones y espec?menes de herbario recopilados por Joan Mont?n desde 1996 hasta el presente, principalmente en Catalu?a y Arag?n, y cuenta con numerosos registros del Pirineo. Existen espec?menes de herbario de 1955 de los registros (referencias en el campo OtherCatalogNumbers). Aquellos que acaban en D (por ejemplo, 1000D) se encuentran depositados en el herbario particular de Joan Monton, mientras que aquellos en los que s?lo consta un n?mero (por ejemplo, 487) est?n depositados en el Herbarium Illerdense (HBIL), localizado en el Institut d'Estudis Ilerdencs en Lleida. El juego de datos contiene registros de especies poco citadas y potencialmente amenazadas en la Pen?nsula Ib?rica.
DOI: 10.15468/9secab
title: Données mycologiques bibliographiques issues du Bulletin de la Société Mycologique de France

description: Données mycologiques extraites du Bulletin de la Société Mycologique de France (SMF, Paris) - saisies 2021
DOI: 10.15468/v2raf8
title: 30 - Inventaires mycologiques - R.N. des hauts de Villaroger

description: R.N. des hauts de Villaroger
DOI: 10.15468/485yak
title: Mushrooms Flora of Nepal at National Herbarium and Plant Laboratories (KATH)

description: This occurrence database contains records of the lichens based on the herbarium specimens deposited at the National Herbarium and Plant Laboratories (KATH), Godawari, Lalitpur, Nepal. Established in 1961, it is the largest and Government's owned Herbarium with about 165,000 specimens. The cryptogams section in this KATH focuses on the collection, identification and documentation of lower group of plants: Algae, Fungi and Lichens collected from different parts of Nepal. This database is a part of a project funded by the Biodiversity Information Fund for Asia (BIFA; project no. BIFA5_023 to Shiva Devkota) program of Global Biodiversity Information Facility (GBIF) supported by the Ministry of Environment, Government of Japan and co-funding came from the Himalayan Climate & Science Institute (HCSI), ForestAction Nepal and Global Institute for Interdisciplinary Studies (GIIS).
DOI: 10.15468/364v8g
title: 25 - Programme d'inventaire MycoflAURA - MycoflAURA RT 2017

description: MycoflAURA RT 2017 / Acquisition de données d'inventaire de la fonge d'Auvergne-Rhône-Alpes dans le cadre d'une convention entre la FMBDS et les associations ou les mycologues régionaux
DOI: 10.15468/6rp46j
title: Atlas mycologique des Hauts-de-France données SMNF associatives - SMNF, données associatives jusqu'au 31/12/2009

description: Observations réalisées par les membres de la SMNF (Lille) lors d'excursions et stages organisés par l'association, regroupées dans le projet Atlas mycologique des Hauts-de-France (hdf.adonif.fr)
DOI: 10.15468/c2sus4
title: Mushrooms Flora of Nepal at Natural History Museum

description: This occurrence database contains records of the mushrooms based on the herbarium specimens deposited at the Natural History Museum (NHM), Tribhuvan University Nepal. Situated on the lap of a world heritage site Swayambhu Stupa, this is the only natural history museum of Nepal with major objectives to collect, preserve and demonstrates flora, faunal, geological, and other natural specimens. This database is a part of a project funded by the Biodiversity Information Fund for Asia (BIFA; project no. BIFA05_23 to Shiva Devkota) program of Global Biodiversity Information Facility (GBIF) supported by the Ministry of Environment, Government of Japan and co-funding came from the Himalayan Climate & Science Institute (HCSI), ForestAction Nepal and Global Institute for Interdisciplinary Studies (GIIS).
DOI: 10.15468/p24ukj
title: Données mycologiques FongiFrance-Inventaire mycologique de Haute-Normandie - J.-C. Malaval

description: Données compilées par Jean-Claude Malaval sur la Haute-Normandie, ayant servi à la publication de la " Liste rouge – Ascomycotina, Basidiomycotina, Myxostelidae menacés de Haute-Normandie" (Rouen, Soc. des Amis des Sc. Nat. et du Museum de Rouen, 2000)
DOI: 10.15468/g3c5mk
title: Données mycologiques personnelles et associatives Ile-de-France-Données mycologiques associatives Soc. Mycol. Montgeron

description: Données associatives fournies à AdoniFpar la Société Mycologique de Montgeron (91)
DOI: 10.15468/2sqhgf
title: Atlas Mycologique des Hauts-de-France - Données diverses-Données mycologiques associatives ABMARS (Senlis) 2021

description: Données associatives fournies par l'ABMARS (Senlis) dans le cadre du projet Atlas Mycologique des Hauts-de-France (hdf.adonif.fr) jusqu'au 31/12/2021
DOI: 10.15468/k2jtfb
title: Inventaires des espaces protégés de la LPO France et de l'OFB - Inventaire Fonges 2016-2018 | RNN Marais d'Yves

description: Inventaire fonge effectué, entre 2016 et 2018, sur la Réserve Naturelle nationale du Marais d'Yves.
DOI: 10.21227/9kq3-xh59
title: IEEEXtreme 12: PIEEEXMan

description: This dataset contains a total of 1784 submissions, with 0% correct solutions and 70% partial solutions. Link to the original challenge: https://csacademy.com/ieeextreme-practice/task/pieeexman/ See the included PDF document for details about the original challenge.
DOI: 10.6084/m9.figshare.21427394
title: Additional file 1 of Seasonal distribution of Cryptosporidium spp., Giardia duodenalis and Enterocytozoon bieneusi in Tibetan sheep in Qinghai, China

description: Additional file 1. Dataset S1. The nucleotide sequences detected on the triosephosphate isomerase (TPI) genetic locus of Giardia duodenalis.
DOI: 10.6084/m9.figshare.21427394.v1
title: Additional file 1 of Seasonal distribution of Cryptosporidium spp., Giardia duodenalis and Enterocytozoon bieneusi in Tibetan sheep in Qinghai, China

description: Additional file 1. Dataset S1. The nucleotide sequences detected on the triosephosphate isomerase (TPI) genetic locus of Giardia duodenalis.
DOI: 10.6084/m9.figshare.21427382
title: Additional file 2 of Transcriptome and Metabolome Analyses Reveals the Pathway and Metabolites of Grain Quality Under Phytochrome B in Rice (Oryza sativa L.)

description: Additional file 2. Table S2. Gene names and numbers for differential pathways.
DOI: 10.6084/m9.figshare.21427382.v1
title: Additional file 2 of Transcriptome and Metabolome Analyses Reveals the Pathway and Metabolites of Grain Quality Under Phytochrome B in Rice (Oryza sativa L.)

description: Additional file 2. Table S2. Gene names and numbers for differential pathways.
DOI: 10.25582/data.2023-04.2785663/2337011
title: Data for EMSL Project 51287 from April 2023
DOI: 10.15468/dl.6h8gzg
title: Occurrence Download

description: A dataset containing 170 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Saurauia bracteosa DC."
 ]
}

 The dataset includes 170 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0149613-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.agj7hx
title: Occurrence Download

description: A dataset containing 15 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Oncidium cinnamomeum (R.Warner & B.S.Williams) M.W.Chase & N.H.Williams"
 ]
}

 The dataset includes 15 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0183161-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.j9y5er
title: Occurrence Download

description: A dataset containing 11160 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Melaleuca quinquenervia (Cav.) S.T.Blake",
 "OccurrenceStatus is Present"
 ]
}

 The dataset includes 11160 records from 150 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0003857-231002084531237/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.peiuss
title: Occurrence Download

description: A dataset containing 7287 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Carex buxbaumii Wahlenb.",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 7287 records from 97 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0000278-150407101314760/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25582/data.2023-04.2785241/2337012
title: Data for EMSL Project 51287 from April 2023
DOI: 10.15468/dl.uddp4r
title: Occurrence Download

description: A dataset containing 3 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Peperomia litana Trel. & Yunck."
 ]
}

 The dataset includes 3 records from 3 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0183162-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.hyanft
title: Occurrence Download

description: A dataset containing 889 species occurrences available in GBIF matching the query:
{
 "and" : [
 "DatasetKey is EOD – eBird Observation Dataset",
 "TaxonKey is Fulmarus glacialis (Linnaeus, 1761)",
 "Year 2005-2005"
 ]
}

 The dataset includes 889 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0149687-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.dnz9vq
title: Occurrence Download

description: A dataset containing 670 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Campylanthus salsoloides Roth"
 ]
}

 The dataset includes 670 records from 60 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0013108-231120084113126/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.vit2mn
title: Occurrence Download

description: A dataset containing 196 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Achillea clavennae L.",
 "HasGeospatialIssue is false",
 "HasCoordinate is true"
 ]
}

 The dataset includes 196 records from 20 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0000278-150504100648427/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25582/data.2023-04.2786228/2337013
title: Data for EMSL Project 51287 from April 2023